Gliclazide Mylan Generics Italia

Gliclazide Mylan Generics Italia is an oral medication used to manage type 2 diabetes. It helps control blood sugar levels by stimulating insulin production. This medication is part of the sulfonylurea class and is manufactured by Mylan S.P.A.

Gliclazide is primarily used to treat type 2 diabetes by helping the pancreas produce more insulin. It is often prescribed for individuals who cannot control their blood sugar levels through diet and exercise alone. This medication is part of a broader category of drugs known as sulfonylureas, which work by stimulating the beta cells in the pancreas to release more insulin. Gliclazide is typically used in combination with a balanced diet and regular physical activity to achieve optimal blood sugar control.

Common effects of Gliclazide may include hypoglycemia, or low blood sugar, which can cause symptoms such as sweating, dizziness, and confusion. Other potential effects include nausea, vomiting, and stomach discomfort. It is important to monitor blood sugar levels regularly while taking this medication to avoid severe hypoglycemia. Some individuals may also experience weight gain or allergic reactions, although these are less common.

Gliclazide should be handled with care, especially by individuals with a history of liver or kidney problems. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored at room temperature and kept out of reach of children. Regular blood sugar monitoring is essential to avoid complications associated with hypoglycemia or hyperglycemia.

Gliclazide may interact with other medications, including those that lower blood sugar, such as insulin or other oral hypoglycemic agents. It is also important to be cautious when taking Gliclazide with medications that affect liver enzymes, as this can alter the effectiveness of the drug. Alcohol consumption should be limited while taking Gliclazide, as it can increase the risk of hypoglycemia. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.